|
HAT1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.71780000000266E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.798890E-03 |
| Normal-vs-Stage2 |
3.403600E-02 |
| Normal-vs-Stage3 |
2.2884999999917E-05 |
| Normal-vs-Stage4 |
3.552200E-04 |
| Stage1-vs-Stage2 |
7.867400E-01 |
| Stage1-vs-Stage3 |
4.582400E-02 |
| Stage1-vs-Stage4 |
1.281830E-01 |
| Stage2-vs-Stage3 |
3.316800E-01 |
| Stage2-vs-Stage4 |
5.087000E-01 |
| Stage3-vs-Stage4 |
7.395600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.57410000000736E-05 |
| Normal-vs-AfricanAmerican |
9.50899999999644E-05 |
| Normal-vs-Asian |
1.111050E-01 |
| Caucasian-vs-AfricanAmerican |
2.689200E-01 |
| Caucasian-vs-Asian |
9.218200E-01 |
| AfricanAmerican-vs-Asian |
7.010200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.21639999994816E-06 |
| Normal-vs-Female |
1.614000E-02 |
| Male-vs-Female |
7.324100E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.167200E-04 |
| Normal-vs-Age(41-60Yrs) |
3.828300E-04 |
| Normal-vs-Age(61-80Yrs) |
4.213000E-04 |
| Normal-vs-Age(81-100Yrs) |
1.006280E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.886800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.871000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.826800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.231600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.091000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.418800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.711000E-01 |
| Normal-vs-Grade 2 |
3.530200E-02 |
| Normal-vs-Grade 3 |
3.54520000023228E-07 |
| Normal-vs-Grade 4 |
2.04209999999927E-05 |
| Grade 1-vs-Grade 2 |
9.867800E-01 |
| Grade 1-vs-Grade 3 |
1.499650E-01 |
| Grade 1-vs-Grade 4 |
5.056000E-02 |
| Grade 2-vs-Grade 3 |
4.564000E-04 |
| Grade 2-vs-Grade 4 |
3.921100E-03 |
| Grade 3-vs-Grade 4 |
5.183800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.598020E-01 |
| Normal-vs-ccB subtype |
2.78529999953037E-07 |
| ccA subtype-vs-ccB subtype |
1.62276999999822E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.754600E-04 |
| Normal-vs-N1 |
1.043770E-02 |
| N0-vs-N1 |
4.466000E-01 |
|
|
